SCHEMBL6155423

SCHEMBL6155423

CSc1ccc(C(=O)NNC(=S)Nc2ccc(Cl)c(Cl)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.56
PLA2G10 O15496 1/20 0.56
PHGDH O43175 1/20 0.56
F2 P00734 1/20 0.56
PLA2G1B P04054 1/20 0.56
ARG1 P05089 1/20 0.56
LCK P06239 1/20 0.56
HTR1A P08908 1/20 0.56
CHRM1 P11229 1/20 0.56
ACE P12821 1/20 0.56
PLA2G2A P14555 1/20 0.56
GABRA1 P14867 1/20 0.56
IDO1 P14902 1/20 0.56
MAOA P21397 1/20 0.56
CNR1 P21554 1/20 0.56
ACHE P22303 1/20 0.56
PTGS1 P23219 1/20 0.56
PLA2G5 P39877 1/20 0.56
GABRB2 P47870 1/20 0.56
PPARA Q07869 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154935 0.81 GAA (0.67) CA2PLA2G10PHGDHF2PLA2G1B
SCHEMBL7517330 0.73 GUSB (0.53) CA2PLA2G10PHGDHF2PLA2G1B
SCHEMBL5445610 0.73 MAPT (0.71) IDO1MAPTRAB9AMEN1KMT2A
SCHEMBL6667399 0.72 MAPT (0.61) CA2PLA2G10PHGDHF2PLA2G1B
SCHEMBL19472682 0.72 CA2 (0.68) CA2CHRM1IDO1PDE3AMAPT
SCHEMBL6155430 0.72 MAPT (0.57) CA2PLA2G10PHGDHF2PLA2G1B
SCHEMBL19478518 0.72 CA2 (0.71) CA2CHRM1IDO1PDE3AMAPT
SCHEMBL14096534 0.71 RAB9A (0.62) MAPTRAB9AMEN1KMT2AGAA
SCHEMBL4555003 0.71 IDO1 (0.78) IDO1MAPTRAB9AMEN1KMT2A
SCHEMBL6154198 0.71 GAA (0.74) MAPTRAB9AMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP CA2 3937/4885PLA2G10 2249/4885PHGDH 453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.